Literature DB >> 33399865

Impact of biological sex on cryptococcal meningitis mortality in Uganda and South Africa.

Anna M Stadelman1,2,3, Kenneth Ssebambulidde3, Lillian Tugume3, Katelyn A Pastick2,3, Kathy Huppler Hullsiek4, Sarah Lofgren2, Edwin Nuwagira5, Emily E Evans5, Darlisha A Williams2,3, Conrad Muzoora5, David B Meya2,3,6, Radha Rajasingham2,7, Joshua Rhein2,3, David R Boulware2,7.   

Abstract

The role of biological sex on clinical outcomes and the pathogenesis of AIDS-related opportunistic infections is unknown. We assessed baseline biomarkers and outcomes between 577 men and 400 women in HIV-related cryptococcal meningitis cohorts in Uganda and South Africa from 2010 to 2017. We compared 10-week mortality by sex via Cox proportional hazards models. The 10-week mortality for women was 50% (198/400) and 43% (247/577) for men. Women had higher risk of death in an unadjusted model (Hazard Ratio (HR) = 1.20; 95%CI, 1.00-1.45; P = .05). Women maintained a higher risk when adjusting for quantitative CSF culture, altered mental status, CSF pleocytosis, age, and antiretroviral status (HR = 1.31; 95%CI, 1.07-1.59; P < .01). However, after adjusting for hemoglobin, the risk of death did not differ between women and men (HR = 1.17; 95%CI, 0.94-1.45; P = .17). Moderate to severe anemia (hemoglobin < 8.5 g/dL) was present among 16% (55/355) of women and 10% (55/532) of men (P = .02). Of the 373 participants with CSF biomarkers, men had higher median pro- and anti-inflammatory, monocyte/macrophage differentiation, maturation, and migration, immune exhaustion, and cytotoxicity cytokines than women (P < .05). We identified biological sex as proxy for anemia, a potentially modifiable risk factor for cryptococcal meningitis mortality. Immune response may contribute to the multifaceted underlying mechanisms for the discrepancy in mortality based on sex. LAY
SUMMARY: We examined the role of biological sex in cryptococcal meningitis mortality in a large cohort. Our findings reveal significant differences in inflammatory markers by biological sex. Women have significantly higher mortality due to cryptococcal meningitis that is attributable to anemia at baseline.
© The Author(s) 2021. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Entities:  

Keywords:  HIV; South Africa; Uganda; biological sex; cryptococcal meningitis; cytokines; immunology

Mesh:

Substances:

Year:  2021        PMID: 33399865      PMCID: PMC8257409          DOI: 10.1093/mmy/myaa108

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  19 in total

1.  Stimulation of phagocytosis of Cryptococcus neoformans in human cryptococcal meningitis.

Authors:  J A Mohr; H G Muchmore; R Tacker
Journal:  J Reticuloendothel Soc       Date:  1974-02

2.  Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.

Authors:  Radha Rajasingham; Rachel M Smith; Benjamin J Park; Joseph N Jarvis; Nelesh P Govender; Tom M Chiller; David W Denning; Angela Loyse; David R Boulware
Journal:  Lancet Infect Dis       Date:  2017-05-05       Impact factor: 25.071

3.  Anemia in human immunodeficiency virus-infected and uninfected women in Rwanda.

Authors:  Florence Masaisa; Jean Bosco Gahutu; Joshua Mukiibi; Joris Delanghe; Jan Philippé
Journal:  Am J Trop Med Hyg       Date:  2011-03       Impact factor: 2.345

4.  Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.

Authors:  Asha R Kallianpur; Quan Wang; Peilin Jia; Todd Hulgan; Zhongming Zhao; Scott L Letendre; Ronald J Ellis; Robert K Heaton; Donald R Franklin; Jill Barnholtz-Sloan; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David M Simpson; J A McCutchan; Igor Grant
Journal:  J Infect Dis       Date:  2015-12-21       Impact factor: 5.226

5.  Epidemiology of meningitis in an HIV-infected Ugandan cohort.

Authors:  Radha Rajasingham; Joshua Rhein; Kate Klammer; Abdu Musubire; Henry Nabeta; Andrew Akampurira; Eric C Mossel; Darlisha A Williams; Dave J Boxrud; Mary B Crabtree; Barry R Miller; Melissa A Rolfes; Supatida Tengsupakul; Alfred O Andama; David B Meya; David R Boulware
Journal:  Am J Trop Med Hyg       Date:  2014-11-10       Impact factor: 2.345

6.  Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection.

Authors:  Yi-Chien Lee; Jann-Tay Wang; Hsin-Yun Sun; Yee-Chun Chen
Journal:  J Microbiol Immunol Infect       Date:  2011-01-20       Impact factor: 4.399

7.  Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells.

Authors:  B F Bebo; J C Schuster; A A Vandenbark; H Offner
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

8.  Cryptococcal meningitis in a tertiary hospital in Pretoria, mortality and risk factors - A retrospective cohort study.

Authors:  J Hiesgen; C Schutte; S Olorunju; J Retief
Journal:  Int J STD AIDS       Date:  2016-07-10       Impact factor: 1.359

9.  Prevalence and clinical presentation of Cryptococcal meningitis among HIV seropositive patients.

Authors:  Vasant Baradkar; M Mathur; A De; S Kumar; M Rathi
Journal:  Indian J Sex Transm Dis AIDS       Date:  2009-01

10.  Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan.

Authors:  Lauren E Yauch; Jennifer S Lam; Stuart M Levitz
Journal:  PLoS Pathog       Date:  2006-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.